KalVista Pharmaceuticals, Inc. ($KALV)
Filing Information
| Accession Number | 0001860131-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | May 26, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
15,185
Total Value
$71,916.11
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF MEDICAL OFFICER | Common Stock | โ | May 21, 2026 | Exercise/Conversion | 6,250 | โ | โ | 150,184 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | May 22, 2026 | Sale | 2,685 | $26.78 | $71,916.11 | 147,499 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Restricted Stock Unit | Derivative | May 21, 2026 | Exercise/Conversion | 6,250 | $0.00 | $0.00 | 68,750 | Direct | โ | View Details |